Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling.

Saldanha-Araujo F, Haddad R, Farias KC, Souza Ade P, Palma PV, Araujo AG, Orellana MD, Voltarelli JC, Covas DT, Zago MA, Panepucci RA.

J Cell Mol Med. 2012 Jun;16(6):1232-44. doi: 10.1111/j.1582-4934.2011.01391.x.

2.

Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB.

Dorronsoro A, Ferrin I, Salcedo JM, Jakobsson E, Fernández-Rueda J, Lang V, Sepulveda P, Fechter K, Pennington D, Trigueros C.

Eur J Immunol. 2014 Feb;44(2):480-8. doi: 10.1002/eji.201343668. Epub 2013 Dec 4.

3.

Induction of CD69 expression by cagPAI-positive Helicobacter pylori infection.

Mori N, Ishikawa C, Senba M.

World J Gastroenterol. 2011 Aug 28;17(32):3691-9. doi: 10.3748/wjg.v17.i32.3691.

4.

CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation.

Ishikawa C, Kawakami H, Uchihara JN, Senba M, Mori N.

Biochim Biophys Acta. 2013 Jun;1833(6):1542-52. doi: 10.1016/j.bbamcr.2013.03.006. Epub 2013 Mar 16.

5.

Human T cells upregulate CD69 after coculture with xenogeneic genetically-modified pig mesenchymal stromal cells.

Li J, Andreyev O, Chen M, Marco M, Iwase H, Long C, Ayares D, Shen Z, Cooper DK, Ezzelarab MB.

Cell Immunol. 2013 Sep-Oct;285(1-2):23-30. doi: 10.1016/j.cellimm.2013.08.004. Epub 2013 Aug 29.

6.

Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.

Cipriani P, Di Benedetto P, Liakouli V, Del Papa B, Di Padova M, Di Ianni M, Marrelli A, Alesse E, Giacomelli R.

Clin Exp Immunol. 2013 Aug;173(2):195-206. doi: 10.1111/cei.12111.

7.

The early activation marker CD69 regulates the expression of chemokines and CD4 T cell accumulation in intestine.

Radulovic K, Rossini V, Manta C, Holzmann K, Kestler HA, Niess JH.

PLoS One. 2013 Jun 12;8(6):e65413. doi: 10.1371/journal.pone.0065413. Print 2013.

8.

Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.

Checker R, Sharma D, Sandur SK, Khanam S, Poduval TB.

Int Immunopharmacol. 2009 Jul;9(7-8):949-58. doi: 10.1016/j.intimp.2009.03.022. Epub 2009 Apr 15.

PMID:
19374955
9.

[Effect of mesenchymal stem cells on expression of CD69 in cord blood CIK/NK cells and quantity ratio of T regulatory cells in CIK/NK cell culture].

Li Y, Wei J, Wu YF, Wang XP, Huang K, Lin YC, Huang SL, Fang JP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Oct;17(5):1301-6. Chinese.

PMID:
19840471
11.

CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.

Radulovic K, Manta C, Rossini V, Holzmann K, Kestler HA, Wegenka UM, Nakayama T, Niess JH.

J Immunol. 2012 Feb 15;188(4):2001-13. doi: 10.4049/jimmunol.1100765. Epub 2012 Jan 16.

12.

Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity.

Yang SP, Ho LJ, Lin YL, Cheng SM, Tsao TP, Chang DM, Hsu YL, Shih CY, Juan TY, Lai JH.

Cardiovasc Res. 2003 Sep 1;59(3):776-87.

13.

Curcumin inhibits CD4(+) T cell activation, but augments CD69 expression and TGF-β1-mediated generation of regulatory T cells at late phase.

Kim G, Jang MS, Son YM, Seo MJ, Ji SY, Han SH, Jung ID, Park YM, Jung HJ, Yun CH.

PLoS One. 2013 Apr 26;8(4):e62300. doi: 10.1371/journal.pone.0062300. Print 2013. Erratum in: PLoS One. 2013;8(5). doi: 10.1371/annotation/631b0f02-bf10-4bac-88a3-c986f2b73284.

15.

CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation.

Martín P, Gómez M, Lamana A, Cruz-Adalia A, Ramírez-Huesca M, Ursa MA, Yáñez-Mo M, Sánchez-Madrid F.

Mol Cell Biol. 2010 Oct;30(20):4877-89. doi: 10.1128/MCB.00456-10. Epub 2010 Aug 9.

16.

Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.

Luz-Crawford P, Kurte M, Bravo-Alegría J, Contreras R, Nova-Lamperti E, Tejedor G, Noël D, Jorgensen C, Figueroa F, Djouad F, Carrión F.

Stem Cell Res Ther. 2013 Jun 4;4(3):65. doi: 10.1186/scrt216.

17.

Non-traditional CD4+CD25-CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation.

Zhao XS, Wang XH, Zhao XY, Chang YJ, Xu LP, Zhang XH, Huang XJ.

J Transl Med. 2014 Jul 1;12:187. doi: 10.1186/1479-5876-12-187.

18.

Vitamin D does not modulate NF-kappaB activity in Jurkat T cells.

Shifera AS, Leong D, Hardin JA.

Immunol Lett. 2010 Jul 8;131(2):151-8. doi: 10.1016/j.imlet.2010.04.001. Epub 2010 Apr 10.

20.

Regulation of p53 and Rb links the alternative NF-κB pathway to EZH2 expression and cell senescence.

Iannetti A, Ledoux AC, Tudhope SJ, Sellier H, Zhao B, Mowla S, Moore A, Hummerich H, Gewurz BE, Cockell SJ, Jat PS, Willmore E, Perkins ND.

PLoS Genet. 2014 Sep 25;10(9):e1004642. doi: 10.1371/journal.pgen.1004642. eCollection 2014 Sep.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk